STAT September 19, 2022
Ambar Castillo

Rep. Robin Kelly admits that the word “diversity” has scared some of her Republican colleagues away from her effort to improve representation in clinical trials.

“It’s been a little tough on the other side of the aisle,” Kelly said at a recent STAT event. “I don’t want to put one broad brush on everybody, but … they feel like the government’s putting their nose in something a little bit too much.”

The Illinois Democrat has already managed to get one GOP co-sponsor on board with her bill, the NIH Clinical Trial Diversity Act of 2022, which would require clinical trial sponsors to write formal diversity plans when they apply for funding from the National Institutes of Health. If it passes,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Congress / White House, Equity/SDOH, Govt Agencies, Healthcare System, Regulations, Trends
“Intentional effort” needed from sponsors to achieve diversity in oncology clinical trials
It’s Time to Give Patients a Seat at the Table
LabConnect Agrees to Acquire A4P Consulting
Q&A: Bring your own device: How patients own tech is being used in clinical trials
With $75m cash injection, SynOx plans ph3 rare tumour trial

Share This Article